Published by
@ShahidNShah
@ShahidNShah
Pharma And Startups Have A Lot To Offer Each Other. What's Going Wrong?
Digital health has the potential to transform the pharmaceutical industry and the patient experience. Both digital health startups and pharma are eager to engage each other. Pharma continues to have significant need to leverage innovative "beyond the pill solutions."
Digital health startups offer a wealth of potential solutions, and investors have noticed. Such startups attracted over $6.7 billion in Q1 2021 alone.
Given the potential synergy, why aren’t we hearing more pharma-startup success stories? Simply put, there is a "pharma-startup gap," a disconnect due to the divergent ways pharma and startups operate. Differences in size, speed, processes and culture make it challenging for pharma and startups to partner.
Continue reading at mobihealthnews.com
Make faster decisions with community advice
- Gamification Of Step Count Leads To More Activity In Diabetes-Focused Study
- Study Finds Success In Using Taiwanese Medication Safety AI Model For US' EHR Systems
- This Is How A.I. Will Transform Medicine
- Virtual Care: Telehealth Must Be More Than Just Video Visits
- What The Future of Healthcare In The Home Will Look Like
Next Article
-
Study Finds Success In Using Taiwanese Medication Safety AI Model For US' EHR Systems
The study also found that applying a federated learning approach can further improve accuracy of the model. A study has demonstrated the international transferability of a Taiwanese artificial …
Posted May 26, 2021 Artificial Intelligence EHR (Electronic Health Record) Medication Management
